Nucynta Tablet, Film Coated
Product Images NDC 24510-075

6 FDA label images from Collegium Pharmaceutical, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nucynta (NDC 24510-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Collegium Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nucynta 01)

Chemical Structure (Nucynta 01)
Chemical structure diagram of tapentadol hydrochloride, showing the molecular arrangement with a phenol group and dimethylamine substituent, associated with its hydrochloride salt form.*
FDA Label Image

Figure 1 (Nucynta 02)

Figure 1 (Nucynta 02)
A line graph showing the percent of patients improved plotted against percent improvement in pain from baseline at hour 48. The graph compares placebo and three Nucynta (tapentadol hydrochloride) dosages: 50 mg, 75 mg, and 100 mg. Each dosage is represented by a distinct line style, with percent improvement ranging from 0 to 100% on the x-axis and percent of patients improved on the y-axis.*
FDA Label Image

Figure 2 (Nucynta 03)

Figure 2 (Nucynta 03)
Line graph comparing percent improvement in pain from baseline on Day 5 among patients treated with placebo, Nucynta 50 mg, and Nucynta 75 mg. The x-axis shows percent improvement from 0 to 100, and the y-axis shows percent of patients improved from 0% to 100%. Three separate lines represent placebo (dashed), Nucynta 50 mg (dotted), and Nucynta 75 mg (solid), illustrating differences in patient responses across improvement levels.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Label for Nucynta (tapentadol) tablets, 50 mg strength, film coated, oral route. The label indicates the package contains 100 tablets and is distributed by Collegium Pharmaceutical, Inc. It includes a Drug Enforcement Administration Schedule II symbol, dosage strength, and storage instructions.*
FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Label)

Principal Display Panel (75 mg Tablet Bottle Label)
Nucynta 75 mg (tapentadol) film-coated tablets label showing packaging for 100 oral tablets. The label includes dosage strength, NDC number 24510-075-10, and manufacturer Collegium Pharmaceutical, Inc. It contains cautionary statements about prescription transfer and medication guide dispensing along with storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Nucynta 100 mg film-coated tablets label for oral use. The label states the active ingredient as tapentadol 100 mg per tablet, with a package count of 100 tablets. It shows the NDC number 24510-100-10 and is distributed by Collegium Pharmaceutical, Inc. Storage instructions and cautionary warnings are also included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.